A feasibility study of the childhood depression medication algorithm: the Texas Children's Medication Algorithm...

Area of Science:

• Child and Adolescent Psychiatry
• Mental Health Services Research
• Digital Health Interventions

Background:

• Community mental health centers face challenges in managing pediatric depression and ADHD.
• Standardized treatment approaches are needed to improve clinical outcomes for youth with these conditions.

Purpose of the Study:

• To assess the feasibility and impact of an algorithm-driven disease management program (ALGO) for children and adolescents with depression, with or without ADHD.
• To evaluate ALGO's effect on clinical response and functional outcomes in a community mental health setting.

Main Methods:

• The ALGO program integrated medication algorithms, physician support, outcome documentation, and patient/family psychoeducation.
• A quasi-experimental design compared 39 children treated with ALGO to a historical chart cohort of 114 children.
• Outcomes measured included clinical symptoms (Children's Depression Rating Scale-Revised), functioning (Child Adolescent Functioning Assessment Scale), and global improvement (Clinical Global Impression Scale) over 4 months.

Main Results:

• ALGO treatment significantly reduced depression severity scores (48.2 to 32.5, p <.0005) and improved functioning scores (70.3 to 40.9, p <.0005).
• Global improvement scores showed a greater decrease in the ALGO group (5.7 to 3.7) compared to the control group (5.8 to 4.8, p <.003).

Conclusions:

• Algorithm-driven disease management (ALGO) demonstrated clear improvements in clinical symptoms, functioning, and global response in children and adolescents.
• The ALGO program yielded superior outcomes compared to a historical cohort, supporting its potential for pediatric mental health care.
• Further controlled studies are warranted to examine the effects of ALGO on clinical outcomes in larger pediatric populations.